Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$7.35 - $13.21 $12,803 - $23,011
-1,742 Reduced 48.93%
1,818 $13,000
Q1 2023

May 12, 2023

SELL
$7.79 - $16.29 $1,215 - $2,541
-156 Reduced 4.2%
3,560 $36,000
Q3 2022

Nov 08, 2022

SELL
$20.09 - $35.8 $3,997 - $7,124
-199 Reduced 2.96%
6,526 $137,000
Q2 2022

Aug 08, 2022

SELL
$27.42 - $43.63 $67,974 - $108,158
-2,479 Reduced 26.93%
6,725 $209,000
Q1 2022

May 17, 2022

SELL
$36.48 - $52.22 $15,686 - $22,454
-430 Reduced 4.46%
9,204 $378,000
Q4 2021

Feb 15, 2022

BUY
$33.11 - $55.01 $32,282 - $53,634
975 Added 11.26%
9,634 $419,000
Q3 2021

Nov 12, 2021

BUY
$50.07 - $66.05 $34,097 - $44,980
681 Added 8.54%
8,659 $434,000
Q2 2021

Jul 30, 2021

BUY
$56.61 - $80.46 $60,685 - $86,253
1,072 Added 15.52%
7,978 $503,000
Q1 2021

May 07, 2021

BUY
$86.23 - $125.19 $129,172 - $187,534
1,498 Added 27.7%
6,906 $642,000
Q4 2020

Feb 12, 2021

BUY
$79.17 - $111.47 $212,729 - $299,519
2,687 Added 98.75%
5,408 $485,000
Q3 2020

Nov 16, 2020

BUY
$81.91 - $134.94 $110,578 - $182,169
1,350 Added 98.47%
2,721 $281,000
Q2 2020

Aug 12, 2020

BUY
$54.33 - $89.52 $71,117 - $117,181
1,309 Added 2111.29%
1,371 $108,000
Q1 2020

May 15, 2020

SELL
$49.34 - $68.76 $10,262 - $14,302
-208 Reduced 77.04%
62 $4,000
Q4 2019

Feb 14, 2020

SELL
$51.21 - $59.06 $512 - $590
-10 Reduced 3.57%
270 $15,000
Q3 2019

Nov 14, 2019

SELL
$40.6 - $57.2 $81 - $114
-2 Reduced 0.71%
280 $15,000
Q2 2019

Aug 14, 2019

BUY
$39.92 - $53.86 $598 - $807
15 Added 5.62%
282 $14,000
Q1 2019

May 15, 2019

BUY
$48.23 - $66.16 $8,392 - $11,511
174 Added 187.1%
267 $13,000
Q4 2018

Jan 31, 2019

BUY
$55.63 - $73.24 $5,173 - $6,811
93 New
93 $6,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $443M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.